WHO recommends Regeneron's Covid antibody treatment for patients at high risk of being hospitalized

A panel of experts representing the WHO has recommended that high-risk COVID-19 patients receive Regeneron's monoclonal antibody treatment to boost their immune systems.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: COVID-19 | Health